Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 21750668.
- Also identified by DOI 10.1371/journal.pmed.1001054 and PMC identifier 3130019.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Jur Strobos and colleagues describe the deliberations of a recent multi-stakeholder meeting discussing the creation of a sustainable global pharmacovigilance system for antiretroviral drugs that would be applicable in resource limited settings.
Medical subject headings
- Adverse Drug Reaction Reporting Systems
- Anti-Retroviral Agents
- Drug Industry